Satnam Overseas Limited
⚠️ Moderate Risk
FEI: 3004256211 • New Delhi, IN-DL • INDIA
FEI Number
3004256211
Location
New Delhi, IN-DL
Country
INDIAAddress
201 Vipps Centre Masjid Moth, Greater Kailash - Ii, New Delhi, IN-DL, India
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
SALMONELLA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain Salmonella, a poisonous and deleterious substance which may render it injurious to health.
Refusal History
Frequently Asked Questions
What is Satnam Overseas Limited's FDA import refusal history?
Satnam Overseas Limited (FEI: 3004256211) has 2 FDA import refusal record(s) in our database, spanning from 1/29/2008 to 1/29/2008.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Satnam Overseas Limited's FEI number is 3004256211.
What types of violations has Satnam Overseas Limited received?
Satnam Overseas Limited has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Satnam Overseas Limited come from?
All FDA import refusal data for Satnam Overseas Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.